(NYSE:DOW), NEW YORK, Oct. 16, 2025 (GLOBE NEWSWIRE) — WHY: Rosen Law Firm, a global investor rights law firm, reminds purchasers of securities of Dow Inc. (NYSE: DOW) between January 30, 2025 and July 23, 2025, both dates inclusive (the “Class Period”), of the important October 28, 2025 lead plaintiff deadline. SO WHAT: If you […]
DOW DEADLINE: ROSEN, GLOBAL INVESTOR COUNSEL, Encourages Dow Inc. Investors to Secure Counsel Before Important Deadline in Securities Class Action – DOW GlobeNewswire October 16, 2025 NEW YORK, Oct. 16, 2025 (GLOBE NEWSWIRE) — WHY: Rosen Law Firm, a global investor rights law firm, reminds purchasers of securities of Dow Inc. (NYSE: DOW) between January
(NYSE:JHX), Bragar Eagel & Squire, P.C. Litigation Partner Brandon Walker Encourages Investors Who Suffered Losses In James Hardie (JHX) To Contact Him Directly To Discuss Their Options If you purchased or acquired stock in James Hardie and would like to discuss your legal rights, call Bragar Eagel & Squire partner Brandon Walker or Marion Passmore
JAMES HARDIE INVESTIGATION: Bragar Eagel & Squire, P.C. Reminds Investors of James Hardie Industries to Contact the Firm Regarding the Ongoing Investigation on Behalf of James Hardie Stockholders GlobeNewswire October 16, 2025 Bragar Eagel & Squire, P.C. Litigation Partner Brandon Walker Encourages Investors Who Suffered Losses In James Hardie (JHX) To Contact Him Directly To
The Law Offices of Howard G. Smith announces that investors with substantial losses have opportunity to lead the securities fraud class action lawsuit against Fluor Corporation (“Fluor” or the “Company”) (NYSE:FLR). IF YOU ARE AN INVESTOR WHO SUFFERED A LOSS IN FLUOR CORPORATION (FLR), CONTACT THE LAW OFFICES OF HOWARD G. SMITHBEFORE NOVEMBER 14, 2025
(NASDAQ:RCEL), Bragar Eagel & Squire, P.C. Litigation Partner Brandon Walker Encourages Investors Who Suffered Losses In Avita (RCEL) To Contact Him Directly To Discuss Their Options If you purchased or acquired stock in Avita and would like to discuss your legal rights, call Bragar Eagel & Squire partner Brandon Walker or Marion Passmore directly at
AVITA MEDICAL INVESTIGATION: Bragar Eagel & Squire, P.C. Reminds AVITA Medical Investors to Contact the Firm Regarding the Ongoing Investigation on Behalf of Stockholders GlobeNewswire October 16, 2025 Bragar Eagel & Squire, P.C. Litigation Partner Brandon Walker Encourages Investors Who Suffered Losses In Avita (RCEL) To Contact Him Directly To Discuss Their Options If you
National plaintiffs' law firm Berger Montague PCannounces a class action lawsuit against MoonLake Immunotherapeutics (NASDAQ: MLTX) (“MoonLake” or the “Company”) on behalf of investors who purchased MoonLake shares during the period ofMarch 10, 2024 through September 29, 2025 (the “Class Period”). https://mma.prnewswire.com/media/232479/berger_montague.jpg Investor Deadline: Investors who purchased MoonLakesecurities during the Class Period may, no later
(NasdaqGM:IRON), Disc is seeking accelerated approval of bitopertin for patients aged 12 years and older with EPP The CNPV program is designed to reduce the drug application review process to 1-2 months WATERTOWN, Mass., Oct. 16, 2025 (GLOBE NEWSWIRE) — Disc Medicine, Inc. (NASDAQ:IRON), a clinical-stage biopharmaceutical company focused on the discovery, development, and commercialization
Disc Medicine Announces Receipt of FDA Commissioner's National Priority Voucher (CNPV) for Bitopertin in Erythropoietic Protoporphyria (EPP) GlobeNewswire October 16, 2025 Disc is seeking accelerated approval of bitopertin for patients aged 12 years and older with EPP The CNPV program is designed to reduce the drug application review process to 1-2 months WATERTOWN, Mass., Oct.